1. A randomised controlled trial of 100 subjects with Coronary Artery Disease showed a reduction in insulin resistance after 16 weeks practice of TM (Archives of Internal Medicine 2006; 166:1218-24).
2. In a study of 60 patients with non-insulin dependent diabetes (Type 2 Diabetes Mellitus) attending a hospital clinic, “good” and “acceptable” control was achieved in 68% after 3 months intake of an MA herbal compound (MA471). “Good” and “acceptable” control was evident in 10 of the 15 patients who had never received drug treatment, in 19 of the 30 patients controlled with oral hypoglycaemic agent (OHA) when the original OHA was replaced with MA471 and in 12 of the 15 patients uncontrolled by maximum doses of OHA when MA471 was added as an adjuvant. MA471 also resulted in significant lowering of total serum cholesterol and triglyceride levels without significant change in HDL cholesterol levels in these patients. Patients also reported overall improvement in quality of life. Alternative Therapies in Clinical Practice 1996; Sept/Oct: 26-31.